A non randomized controlled trial on the comparison of Delta-tocotrienol and Alpha-tocopherol Effects on Non-Alcoholic Fatty Liver Disease. - Trial SLCTR_2019_038
Access comprehensive clinical trial information for SLCTR_2019_038 through Pure Global AI's free database. This Phase 2 trial is sponsored by National University of Medical Sciences and is currently status unknown. The study focuses on Non-Alcoholic Fatty Liver Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2019_038
Phase 2
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2019_038
A non randomized controlled trial on the comparison of Delta-tocotrienol and Alpha-tocopherol Effects on Non-Alcoholic Fatty Liver Disease.
Comparison of Delta-tocotrienol and Alpha-tocopherol Effects on Biochemical Markers, Micro-RNA Expression and Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease
Study Focus
Interventional
Sponsor & Location
National University of Medical Sciences
Pakistan
Timeline & Enrollment
Phase 2
N/A
N/A
ICD-10 Classifications
Alcoholic fatty liver
Alcoholic liver disease, unspecified
Alcoholic liver disease
Liver disease, unspecified
Alcoholic cirrhosis of liver
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2019_038
Non-Device Trial